Heart Matters cover art

All Episodes

Heart Matters — 209 episodes

#
Title
1

Looking Ahead in ATTR-CM Care: Improving Diagnosis, Outcomes, and Equity

2

Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies

3

Diagnosing ATTR-CM: Recent Advances and Future Directions

4

When to Suspect ATTR-CM: Clues for Earlier Diagnosis

5

Understanding the Mechanisms Behind Resistant Hypertension

6

Quality of Life Conversations in ATTR-CM Care

7

Hypertension Across Diverse Populations: Practical Strategies for Equitable Care

8

Cardiometabolic Considerations in Familial Chylomicronemia Syndrome

9

Advances in Sports Cardiology: Updates from ACC 2026

10

Supporting Patients With ATTR-CM: Preserving Function and Quality of Life

11

Counseling Patients on Disease Progression in ATTR-CM

12

AI-Driven Advances in ATTR-CM Care

13

Redefining ATTR Treatment: Key Mechanisms and Emerging Data

14

Advances in ATTR-CM: Evolving Diagnostics and Therapeutics

15

Treating ATTR-CM Early: A Shift From Reactive to Strategic Care

16

Closing Gaps in ASCVD Prevention: Lipid Management Insights from AHA 2025

17

Rethinking Hormones: Testosterone and Estrogen in Women’s Heart Health

18

Targeting Vascular KCNQ5 Channels: A Promising Strategy for Blood Pressure Control

19

Navigating the Vascular Risks of Cancer Therapy: Balancing Cardiac Safety and Tumor Control

20

Understanding Lipid and Lipoprotein Metabolism in Cardiovascular Health

21

Sex-Based Differences in Lipid Management: Implications for Cardiovascular Risk

22

Gender Bias and Heart Health: Improving Cardiovascular Care for Women

23

Managing Cholesterol and Triglyceride Levels: Targeted Nutritional Approaches

24

Managing Statin Intolerance: Practical Approaches and Emerging Non-Statin Options

25

Improving Lipid Management Through Equity-Focused Clinical Strategies

26

Optimizing Cardiovascular Outcomes in Hyperlipidemia Through Risk-Based Care

27

How Artificial Sweeteners Could Be Linked to Heart Disease

28

Allergic Reactions and Cardiac Concerns: Exploring the Heart Disease Link

29

Active Aging: Preventing Heart Failure in Older Women with Exercise

30

AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD

31

Pharmacist-Prescribing and Hypertension Management: An Economic Benefit

32

Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity

33

A Discussion on Statins to Lower CVD Risk for HIV Patients

34

A Discussion on the Updated Recommendations for Managing Dyslipidemia in Adults

35

Identifying Cardiovascular Risk Factors for HIV Patients

36

Exploring Emerging Non-Statin LDL Lowering Therapies

37

Assessing the Effectiveness of Lp(a) Lowering Therapies in Clinical Trials

38

Stanford Surgeons Perform First Beating-Heart Procedure

39

Treating Tricuspid Valve Regurgitation With Novel Replacement Device

40

Exploring the Use of AI to Detect HFpEF

41

Updates from ACC 2023: Examining Transcatheter Repair Study Data

42

Cardio-Oncology: Key Clinical Data from ACC.23

43

The Emerging Field of Cardio-Oncology: A Look at the Multidisciplinary Team

44

The STELLAR Trial: Key Data on Sotatercept for PAH

45

A Look at Lipoprotein(a): Key Screening & Treatment Strategies

46

Anticipated Updates on Statin Intolerance at ACC 2023

47

The Role of Implementation Science in Familial Hypercholesterolemia

48

Updated Guidelines for Youth With Dyslipidemia

49

A Look into the Effectiveness of Dietary Supplements

50

Uncovering the Results of the DELIVER Trial

51

Exploring Novel Tools for PAH: Measuring Severity With a New Blood Test

52

Investigating the Link Between PCOS & CV Risk Factors During Delivery

53

When Climate & Cardiology Overlap: How Climate Change Can Impact Heart Health

54

The miniPUMP: A New Way to Get a Close-Up View of the Heart

55

Improving Adherence Among HF Patients: A Look at the PROMPT-HF Trial

56

What the SODIUM-HF Trial Means for Heart Failure Patients

57

Breaking Down the Criteria for Iron Deficiency in Heart Failure

58

Reviewing the Role of SGLT2 Inhibitors in Heart Failure

59

Looking into Long-Term Cardiovascular Impacts of COVID-19

60

Cardio-Obstetrics: Taking Better Care of Our Pregnant & Postpartum Patients

61

Exploring Xenotransplantation: Is the Future of Heart Transplants Now?

62

One Foundation's Approach to Preventing Sudden Cardiac Death in Young Athletes

63

Ejection Fraction in Heart Failure: Does It Matter?

64

Cardiac Rehabilitation: Key Considerations for Breast Cancer Survivors

65

Diving into Diversity: A Look at Representation in Cardiovascular Clinical Trials

66

Patching Up Cardiovascular Risk

67

Coronary Heart Disease & Postmenopausal Women: Evaluating Risk Through Research

68

Considering Cannabis & the Cardiovascular System: A Look at Patient Outcomes

69

Exploring the Careers of Cardiologists: A Noninvasive Cardiologist's Journey & a First-Year Student's Story

70

Examining Coronary Heart Disease & Psychosocial Stressors

71

Cardiovascular Complications & Pregnancy: What Cardiologists Need to Know

72

How Can Space Travel Affect Our Heart Health?

73

Investigating the Relationship Between Pregnancy Complications & Coronary Disease

74

ASCVD Risk & Women: Investigating Impact on Female Patients

75

Spotlighting Excellence in Cardiology Care Amid the COVID-19 Pandemic

76

An Epidemic Amid a Pandemic: CVD, COVID-19, & the Leading Cause of Death Worldwide

77

Addressing Racial Disparities in Cardiovascular Care

78

Clinical Cardiovascular Care: Antiplatelet & Anticoagulation Strategies

79

Exploring Strategies to Eliminate Disparities in Cardiovascular Care

80

Exploring the Effect of Triglycerides

81

Cardiology Care Amid the COVID-19 Pandemic: Remote-Monitoring Technologies

82

Evaluating Essential Strategies for Reducing the Risk of Cardiovascular Disease

83

Exploring the Prevalence of Congenital Heart Disease in Conjoined Twins

84

Detecting & Diagnosing Diabetes in Cardiology Patients

85

Cardiology Among the Constellations: Exploring Microgravity & Space Flight

86

Assessing Advancements in Preventative Cardiology

87

Evaluating the Updated ACC/AHA Cholesterol Guidelines

88

Showcasing a Hero in Cardiology Care: Dr. Heval Kelli

89

Assessing Advancements in Cardiology: Women & Heart Disease

90

Gazing into the Cardiology Crystal Ball: The Future of Preventive Care

91

At the Heart of Healthcare: Addressing the Future of Cardiology Care

92

Exploring Female Underrepresentation in Heart Failure Research

93

Understanding the Link Between Utero Diabetes & Heart Disease in Young Adults

94

Uncovering Evidence on Blood Pressure Improvements in Americans

95

Sci-Fi in the OR: Utilizing Holograms in Cardiac Ablation Procedures

96

Finding the Answer to How & Why Arteries Age

97

How Does COVID-19 Affect the Heart?

98

Revising CPR to Improve Cardiac Arrest Outcomes Outside the Hospital

99

Identifying Unstable Coronary Plaques

100

Examining Links Between Vitamin D Deficiency and Cardiovascular Disease

101

Genetic Testing for Long QT Syndrome

102

Simple Screening for Older Patients Considering Cardiac Surgery

103

The Obesity Epidemic in Mississippi: A Mirror for the Nation

104

Part 2: A Plant-Based Diet for Preventing and Possibly Reversing Coronary Artery Disease

105

Could Silkworms Help Repair Clogged Arteries?

106

When More Isn't Better: Questioning the Efficacy of Common Cardiovascular Treatments

107

How to Develop Interdisciplinary, Realistic Health Policies in an Era of Health System Reform

108

Does the Entire Healthcare System Need a Redesign?

109

The Complexity of Medication Management for Older Patients with Heart Failure

110

Evaluation of Second Generation Drug-Eluting Stents

111

Part 1: A Plant-Based Diet for Preventing and Possibly Reversing Coronary Artery Disease

112

Faster Treatment of MI with the Help of Wireless EKG Programs

113

PPIs and Antiplatelet Therapy: Weighing the Benefits and Risks

114

Fortilin and Targeted Molecular Therapy for Preventing Atherosclerosis

115

Should We Screen Asymptomatic Patients for Subclinical Atherosclerosis?

116

Methods to Identify Quality in Cardiovascular Practices

117

From Haiti to the US: Public-Private Partnerships in Healthcare

118

Anticoagulation Therapies for Atrial Fibrillation

119

Genetic Clues to Heart Health

120

Comparative-Effectiveness Research on Implantable Cardioverter Defibrillators

121

The 50th Anniversary of the First Prosthetic Heart Valve

122

Expanding the Anti-Arrhythmia Armamentarium: Where Does Dronedarone Fit In?

123

Should We Add ECG to Routine Screening of Young Athletes?

124

Linking Air Pollution and Heart Disease

125

All Things in Moderation: Small Lifestyle Changes for Cardiovascular Health

126

The Clinically Broken Heart: Stress-Induced Cardiomyopathy

127

Catheter Ablation Therapy for Atrial Fibrillation

128

The Road Less Traveled: Recognizing Comorbidities and Non-Traditional Characteristics in Patients With Heart Failure

129

The Myths and Realities of Myocardial Infarction Prevention With Vaccination

130

Doctor as Patient Advocate: Top Tools to Empower Your Patients

131

Modernizing the FDA Premarket Approval Process for Medical Devices

132

The Heart and the Lungs: Linking COPD and Cardiac Output

133

Healthcare Cost Containment and Medical Liability Reform

134

Global Disparities in Arrhythmia Management

135

A Global Issue: Obesity and Improving Cardiovascular Health in Children

136

Heart Disease in Ancient Egyptians

137

Deciphering Meaningful Use of Health Information Technology

138

The Value and Future of the Maintenance of Certification Program

139

Health Reform and Cardiology in the Year Ahead

140

The Future of Medical Device Innovation

141

The Patient-Centered Medical Home: New Delivery Models and Healthcare Reform

142

The Rapid Evolution of Ventricular Assist Devices

143

Transforming the Standard of Care for Acute Coronary Syndromes

144

Glucose Control After Acute Myocardial Infarction

145

Can Autologous Stem Cells Reverse the Damage of a Heart Attack?

146

Future Cardiovascular Disease & the Big Impact of Small Salt Reductions

147

Surpassing the Clipboard: Integrating HIT Into Your Practice

148

Preparing for Medicare Payment Cuts

149

As Prescribed: Meeting the Challenges of Medication Adherence

150

Cardiac Care on Ice: Therapeutic Hypothermia for Cardiac Arrest

151

The Spectrum of Treatment for Left Ventricular Dysfunction

152

When to Screen for Fibromuscular Dysplasia

153

Targeting Anemia, Iron Deficiency for Patients With Heart Failure

154

The Challenges of Defibrillator and Pacemaker Lead Extraction

155

The ARBITER 6-HALTS Trial: Clinical Implications

156

The Advantages of a Collaborative Cardiac Care Model

157

Troponin Assays for Diagnosing Myocardial Infarction

158

New Recommendations for STEMI and PCI

159

The Role of Cardiac Resynchronization in the Prevention of Heart Failure

160

The Hypertension Paradox: Better Treatment, Worse Outcomes

161

Pediatric Heart Disease: The Need for More Rigorous Clinical Evidence

162

When Patients Leave the Hospital, a Healthier Transition

163

My Heart Your Heart: Explanting Pacemakers to Reuse Abroad

164

The Scientific Pursuit of More Precise Care

165

Endoscopic Vein-Graft Harvesting in CABG Procedures

166

Walk for Cardiovascular Health: Programs Around the Country

167

The NCDR Family of Registries: What Clinicians Need to Know

168

Warranties, Integration and Enduring Innovation at Geisinger

169

The Possibility of Cardiac Cell Regeneration

170

Framingham: The Foundation of Modern Heart Research

171

Comparative Effectiveness Research: How to Get There?

172

Where Do Accountable Care Organizations Fit Into Reform?

173

How to Achieve, Measure, and Maintain Quality of Care

174

Cardiac Care for a Young, At-Risk Population in Saudi Arabia

175

National Health Reform and Lessons Learned From California

176

Going Home and Staying Home: Reducing Readmissions

177

Focused Factories: A Path to Reduce Cost and Boost Quality

178

Reducing Childhood Obesity, One Sound Policy at a Time

179

Forging a Path Toward Cardiac Applications for Stem Cells

180

How Close Are We to a Cardiac Polypill?

181

Contraceptive Hormones & CV Disease: Pursuing the Link

182

Stable Coronary Artery Disease: PCI Versus Medical Therapy

183

Women and Heart Disease: Closing the Outcomes Gap

184

The Right Test at the Right Time: Progress in Cardiac Imaging

185

Reforming the FDA's Drug Approval Process

186

The Year Ahead in Cardiology and Health Policy

187

Pre-Operative Cardiac Risk Assessment and Risk Reduction

188

Stroke Prevention in Patients with Atrial Fibrillation

189

With or Without Surgical Backup? Settling the Debate on PCI

190

The Role of Employers in the Health Reform Movement

191

Potential Concerns About the Newest Line of ICD Technology

192

Coronary CT Angiography: To Order or Not to Order?

193

The Cost-Benefit Calculus of CT Angiograms

194

Easing the Healthcare Burden on Small Businesses

195

Industry and Healthcare: Sorting Out Potential Conflicts

196

Treatment Guidelines: The Ongoing Pursuit of Excellence

197

Sudden Cardiac Death in Athletes

198

Examining the Biodegradable Stent

199

A More Definitive Ablation Procedure for Atrial Fibrillation

200

Antiplatelet Therapy After Drug-Eluting Stent Implantation

201

Advances in Managing Atrial Fibrillation

202

Recognizing the Subtle Signs of Aortic Valve Disease

203

Developments in Surgical Therapies for Valve Disease

204

Measures to Improve Quality and Physician Payments

205

Healthcare Reform: An Economist’s Perspective

206

Close a Hole in the Heart, Heal Pain in the Head?

207

Updating Guidelines for Unstable Angina and NSTEMI

208

Updating Guidelines for ST-Elevation MI

209

Hypertrophic Cardiomyopathy: Diagnosis and Treatment